Clive Meanwell of The Medicines Company receives innovation and leadership award

172

Clive Meanwell, the founder and chief executive of The Medicines Company, has received the 2016 Sol J Barer Award for Vision, Innovation and Leadership.

 

Named for the founder, former chairman and chief executive officer of Celgene Corporation, Summit, USA, the Sol J Barer award recognises outstanding research and business leaders who have made significant contributions to the growth and prosperity of the biosciences industry, according to a press release.

 

The award was presented during ceremonies celebrating BioNJ’s 23rd Annual Dinner Meeting and Networking Event held at the Hilton East Brunswick.

 

“Sol Barer is an icon of the bioscience industry, and his dedication and commitment to innovation is nothing short of inspirational. I humbly accept this award on behalf of all of my colleagues at The Medicines Company who achieved so much during 2015 – and we thank the BioNJ Board of Trustees for this honour,” says Clive Meanwell, chief executive officer, The Medicines Company.

 

“Clive is everything a leader should be: a visionary who’s not afraid to challenge the status quo, an innovator who’s respected by patients and caregivers for his compassion and commitment to better understand their challenges, and a leader who knows how to get the job done and how to inspire a team to travel that road with him,” says Debbie Hart, president and chief executive officer, BioNJ.

 

At the same event, The Medicines Company was one of 16 companies who received a BioNJ Innovator Award for a new drug approval in 2015. The company had four drug approvals in the USA in 2015.